Objectil'es. This study was performed to obtain better understanding of the long· term clinical efficacy of directional coronary atherectomy.
Directional coronary atherectomy was developed in an at· tempt to overcome some of the limitations of conventional balloon angioplasty. In theory, controlled excision of atherosclerotic tissue by directional coronary atherectomy might create a larger lumen without the dissections, flaps or thrombus common after angioplasty. This procedure should reduce the incidence of abrupt vessel closure, allow the treatment of complex lesions that might be difficult to approach by conventional angioplasty and leave a smoother lumen less conducive to platelet aggregation, thereby blunt· ing subsequent intimal hyperplasia and reducing the incidence of restenosis (1-3).
The reported acute success and complication rates of direc-Six-month angiographic follow-up was obtained in 77% of the eligible patients. The onrall angiographic restenosis rate was 32 %. Predictors of a lower restenosis rate included a postprocedure lumen diameter >3 mm (24% ys. 39%, p = 0.047), serum cholesterol ::;200 mgldl (18% \'s. 40%, p = 0.018) and recent myocardial infarction (16% \'s. 37%, p = 0.034).
Life-table analysis showed a 2% mortality rate and a 26% incidence of other events (myocardial infarction, repeat re\'ascular· ization) within the 1st year. The annual 5% mortality rate and 7% incidence of other events during years 2 and 3 were related in large part to the existence or progression of disease at other locations.
Conclusions. Six-month angiographic follow-up of patients who underwent directional coronary atherectomy during the 1st 3 years of our experience shows an owrall restenosis rate of 32%, with lower rates in patients with a postatherectomy lumen diameter ~3 mm, cholesterolleyel ::;200 mgldl or a recent myocardial infarction. Few if any e\'ents relating to the site of atherectomy denloped after the 1st year of follow-up.
(J Am Call CardioI1992; 20:1l01-10) tional coronary atherectomy have been favorable (2-7), particularly when certain adverse demographic, vessel and lesion characteristics (for example, calcification, diffuse disease, angulation and vessel tortuosity) are absent (8) (9) (10) . However, the overall acceptance of the procedure has been limited by the perception that late results are no better than those of conventional angioplasty; that is, their restenosis rates are comparable. Although several thousand atherectomy procedures have been performed in the coronary circulation, little has been published on how the long-term clinical and angiographic efficacy of directional coronary atherectomy is affected by various clinical, angiographic and histologic factors. To the extent that the ultimate role of atherectomy will be influenced by a better understanding of what predicts long-term efficacy, we undertook the current evaluation of 225 consecutive directional coronary atherectomy procedures performed at Boston's Beth Israel Hospital.
Methods
Patient group. Between August 5,1988 and July 31,1991, we performed directional coronary atherectomy in 225 Ie-0735-10971921$5,00 sions (190 patients); the procedure accounted for 9% of the 2,146 interventional procedures performed during that period. All patients had objective evidence of myocardial ischemia (either by exercise treadmill testing or by spontaneous rest ischemia) and had a :::70% stenosis believed to be accessible with the atherectomy device. Patients were excluded from the study if their diseased vessel was <2.5 mm in diameter, severely tortuous or heavily calcified.
Atherectomy procedure. All procedures were performed with the Simpson AtheroCath (Devices for Vascular Intervention). The device and details of the procedure have been described previously (3, 4, II) . Premedication with aspirin (325 mg/day ) and dipyridamole (200 mg/day), was started 24 h before the procedure in all patients and continued indefinitely. A 10,000 U bolus of heparin was given after insertion of the arterial sheath (10 or II F) and supplemented as needed to maintain the activated clotting time at >300 s.
The atherectomy device was positioned across the lesion over a 0.014-in. (0.036 cm) guide wire advanced through a 9.5, 10 or IIF guiding catheter (Devices for Vascular Intervention). The number of cuts performed, maximal balloon inflation pressures and the final device size were determined by the reference vessel size and residual stenosis after atherectomy. Generally, a 6F device (3.5-mm working diameter) was used when the reference vessel diameter was <3.0 mm. A 7F device (4-mm working diameter) was used when the reference diameter was :::3 mm or when a significant residual stenosis resulted after the use of higher balloon inflation pressures (40 to 60 psi) with a 6F device. A 7F graft device (4.5-mm working diameter) was used for vessels with a diameter :::4 mm. Although specimens were not routinely weighed during our most recent procedures, our previous experience (4) indicated that a mean of 11.6 ± 6 specimens (weighing an average of 18.5 mg/lesion) were removed. Our approach to tissue removal has not changed since this earlier report. Pre dilation with a conventional angioplasty balloon was performed only when difficulty crossing the lesion occurred or was anticipated because of lesion morphology. The use of conventional angioplasty after successful atherectomy was reserved for an unacceptable residual stenosis, mild to moderate dissections or the rescue of compromised side branches. Sheaths were typically removed on the same day as the procedure once the activated clotting time was <180 s.
Successful directional coronary atherectomy was defined as tissue removal, a residual diameter stenosis <50% without having to use conventional balloon angioplasty after atherectomy and the absence of a major complication (emergency coronary artery bypass graft surgery, Q wave myocardial infarction or death). Procedural success was defined as a residual diameter stenosis <50% (including that obtained by the use of conventional angioplasty balloon after unsuccessful atherectomy) without a major complication. Serum creatine kinase (CK) levels and 12-lead electrocardiograms (ECGs) were obtained on all patients after the procedure and the next day. There were no Q wave myocardial JACC Vol. 20, No. 5 November I, 1992 5 November I, :1101 infarctions, but non-Q wave myocardial infarction was diagnosed when the postprocedure CK level was >200 IUlliter with positive MB isoforms. All atherectomy procedures were performed under a protocol approved by the Committee on Clinical Investigation at Boston's Beth Israel Hospital.
Angiographic analysis. Digital calipers (Fowler Ultra-Cal II) were used to measure the minimal lumen diameter from magnified images obtained in the single most stenotic view before and after directional coronary atherectomy: the diameters of the proximal and distal reference segments were averaged to yield a mean reference diameter. A 9F conventional angioplasty guiding catheter was used as the reference object. As described previously (12) , the aClite gain was defined as the increase in diameter of the treated segment from before to immediately after atherectomy, and late loss was defined as the subsequent decrease in diameter of the treated segment by the time of follow-up angiography. The overall net gain was therefore the difference between the acute gain and late loss.
Tissue analysis. Directional coronary atherectomy specimens were fixed in 10% buffered formalin and embedded in paraffin, and 6-J..tm sections were stained with hematoxylineosin, Masson's trichrome and elastic van Gieson stains. Standard light microscopy was performed by one of us (S.J.S.) with evaluation of specimens for the presence of atherosclerotic plaque, intimal hyperplasia, media, adventitia and thrombus.
Follow-up. Successfully treated patients were advised to have serial exercise testing at I, 3 and 6 months after directional coronary atherectomy. Coronary angiography was performed at 6 months unless earlier angiography was clinically indicated. Angiographic studies that did not show restenosis (diameter stenosis :::50%) were included only if they were performed >4 months after the initial procedure. Clinical follow-up was also obtained by clinic visit or telephone contact.
Statistics. Data were expressed as the mean value ± 1 SD. The Student t test was used for comparison of data between subgroups. The association of restenosis with categoric and continuous variables was analyzed by using chi-square and logistic regression analysis, respectively. Event-free survival was determined by Kaplan-Meier techniques and displayed as a standard survival curve.
Results
Patient group. Our study group was congruent with that seen in most interventional catheterization laboratories, including the high proportion of patients with unstable angina (64%) or recent «6 weeks) myocardial infarction (27%) ( Table I) . Most directional coronary atherectomy procedures were performed in the left anterior descending coronary artery (63%) ( performed in restenotic lesions that had developed after prior conventional angioplasty, atherectomy or laser balloon angioplasty. The majority (97%) of lesions were considered unfavorable for conventional angioplasty because of eccentricity. ostial location or calcification. alone or in combination.
Immediate results. Directional coronary atherectomy was successful in 205 (91%) of 225 lesions (Table 3) . Successful conventional angioplasty was performed in 16 additionallesions after failed atherectomy, bringing the overall procedural success to 221 (98%) of 225 lesions. Successful directional coronary atherectomy was less likely in lesions in 'Success defined as retrieval of tissue, <50% residual stenosis without a major complication (death, Q wave myocardial infarction or emergency coronary bypass surgery). tlncluding conventional angioplasty. Unless otherwise indicated, values are mean values ± 1 SO. DCA = directional coronary atherectomy; Post = after; Pre = before; PTCA = percutaneous transluminal coronary angioplasty; other abbreviations as in Table 2. the right coronary artery (77%) or the left main coronary artery (50%) than for lesions in the left anterior descending artery (94%). Successful atherectomy resulted in an increase in mean lumen diameter from 0.71 :!: 0.39 mm to 2.96 :!: 0.62 mm, with a residual stenosis 00 :!: 16%. Supplemental conventional angioplasty was used infrequently (before in 27 [13%] and after in 22 [11%] of 225 atherectomy procedures).
Complications. Major complications (emergency coronary artery bypass grafting, Q wave myocardial infarction or death) were infrequent (0.5%) ( Table 4) . Elective coronary artery bypass grafting (defined as surgery between 24 h after directional coronary atherectomy and hospital discharge) was needed in 2.6% of patients, typically to treat unsuccessful but uncomplicated atherectomy attempts. Transient abrupt vessel closure of the treated segment occurred in 3.2% of atherectomy attempts, but was invariably managed successfully by conventional or laser balloon angioplasty. Abrupt closure of involved side branches occurred in 3.7% of atherectomy attempts but was also successfully treated with conventional angioplasty in all cases. Vessel perforation (transient localized dye extravasation) was seen in one vein graft lesion, without clinical sequelae. Non-Q wave myocardial infarction (defined here as postprocedure CK >200 IUniter) occurred in 7.4% of patients.
Histology (Table 5 ). Recovery of deep wall components (media [66%]/adventitia [28%]) was frequent. There was no association between retrieval of deep wall components and device size, reference artery diameter or procedural complications. However, the mean reference vessel diameter when adventitia was recovered (3.0 ± 0.71 mm) did tend to be slightly smaller than when it was not recovered (3.24 ± 0.79 mm). One patient showed evidence of local coronary aneurysm at the time of 6-month angiography, without further clinical sequelae or need for repeat revascularization. In this patient, directional coronary atherectomy had been successfully performed for a lesion in a circumflex . lesion with a 6F device at a maximal balloon inflation pressure of 30 psi yielding both media and adventitia.
Intimal hyperplasia was seen in 42% of new native lesions, compared with 91% of rest en otic native lesions (p = 0.(05). Thrombus was seen more frequently (63% vs. 37%) in saphenous vein graft lesions compared with native lesions.
Late results. Six-month angiographic follow-up was obtained in 77% of the patients studied ;::::4 months after directional coronary atherectomy and showed a 32% overall angiographic restenosis rate (defined as diameter stenosis JACC Vol. 20 ;::::50%) ( Table 6 ). There was a trend toward a lower restenosis rate for lesions in the right coronary artery (25%) or saphenous vein graft (28%) than for lesions in the left anterior descending coronary artery (38%, p = NS). Restenosis rates tended to be higher (39% vs. 28%, p = NS) for lesions with prior restenosis versus new lesions.
Insight into these differences in restenosis may be obtained by analyzing the corresponding differences in aClite gain (increase in diameter of the treated segment from before to immediately after directional coronary atherectomy), late loss (decrease in diameter of the treated segment from immediately after atherectomy to the time of follow-up angiography) and net gain (difference between the acute gain and late loss) ( Table 7 ). The overall acute gain was 2.25 ± 0.64 mm with a late loss of 1.07 ± 0.92 mm, yielding a net gain of 1.17 mm. Net gain was largest for right coronary artery, left circumflex coronary artery and saphenous vein graft lesions, corresponding to the lower observed restenosis rates for lesions at these sites compared with those for lesions in the left anterior descending artery. Directional coronary atherectomy of new lesions produced both greater acute gain and less late loss, yielding a better net gain and a trend toward a lower restenosis rate compared with that of lesions with prior restenosis.
Predictors of restenosis. A cholesterol level <200 mg/dl at the time of directional coronary atherectomy, recent myocardial infarction «6 weeks) and postatherectomy lumen diameter;::::3 mm were each univariable predictors ofa lower incidence of restenosis (Table 8 ). There was no adverse influence of recovery of media or adventitia on subsequent restenosis, with a trend toward a lower incidence of restenosis in lesions from which adventitia had been recovered. If these follow-up data are expressed as cumulative frequency distributions (as previously described by Kuntz et al. [12] ), any follow-up percent stenosis (for example, 50%) can be selected to determine the corresponding restenosis rate according to that threshold. Lesions whose postatherectomy lumen diameter was <3 mm (Fig. 1) thus had a restenosis rate of 39%, whereas lesions whose postatherec- tomy lumen diameter was ;;::3 mm had a restenosis rate of 24% (p = 0.047), by using a ;;::50% stenosis definition. Although there was an increase in the late loss for lesions with a postatherectomy lumen diameter ;;::3 mm (Table 7) , net gain remained larger because of the even greater acute gain. Lesions in patients with a serum cholesterol level >200 mg/dl (Fig. 2) Tables I, 3 , and 4.
lesions in patients with a cholesterol level :5200 mg/dl had a restenosis rate of 18% (p = 0.018). Reference vessel size and acute gain were similar for these two groups, but patients with a cholesterol level >200 md/gl had more late loss (1.21 vs. 0.88 mm), which translated into less net gain and a higher observed restenosis rate (Table 7) . Long-term clinical follow-up. Patients were contacted by telephone or clinic visit at 6 weeks, 3 months, 6 months and then annually by the investigators. Follow-up data were available for 188 (99%) of 190 patients, at an average follow-up interval of 18.2 ± 11.9 months. This analysis included all patients, even if the index procedure was unsuccessful. Event-free survival was defined as absence of death, myocardial infarction or repeat revascularization (by percutaneous transluminal coronary angioplasty [PTCA] or coronary artery bypass grafting). Table 9 and Figure 3 show initial and long-term freedom from events as assessed by Kaplan-Meier analysis. In terms of absolute events there was a 2% mortality rate in the 1st year with a 26% incidence of other events (myocardial infarction 1%, repeat angiopia sty 17%, coronary artery bypass grafting 12%). Over the next 2 years, there was an annual 5% mortality rate and 7% incidence of other events (myocardial infarction 2%, repeat angioplasty 3%, coronary artery bypass grafting 2%). During the follow-up period, 10 patients died, 4 had a myocardial infarction, 32 had repeat revascularization by coronary angioplasty and 22 by coronary artery bypass grafting. All revascularization procedures were included as events, even if they were performed for lesions other than one at the site Abbreviations as in Table 4 . of the original atherectomy. Thus, five patients had angioplasty performed and three patients had coronary artery bypass grafting performed on the vessel not treated with atherectomy, despite a patent atherectomy-treated vessel. All late deaths were also included, even though two of the late deaths were of noncardiac causes (pneumonia in one patient, lung cancer in the other).
Discussion
Since Gruentzig's pioneering work in the late 1970s (13) (14) (15) (16) , the technology and techniques of conventional angioplasty have been refined progressively, allowing broader application, improved success and fewer complications (15) . Even so, problems continue to occur with conventional angioplasty because of I) failure to cross a stenosis or occlusion, 2) failure to dilate a rigid or eccentric elastic lesion, 3) abrupt vessel closure~ and 4) restenosis (17) . Directional coronary atherectomy was developed in an attempt to overcome some of these limitations.
Immediate Results
Several reports (3) (4) (5) (6) (7) (8) (9) (10) (18) (19) (20) have demonstrated that directional coronary atherectomy can be performed safely and effectively, despite its frequent use in lesions generally considered to be unfavorable for conventional angioplasty. Our pattern of using it in 9% of coronary revascularization procedures (particularly concentrating on such suboptimal angioplasty lesions) is similar to the 11% utilization rate reported during 1992 at centers having trained operators (Devices for Vascular Intervention, personal communication). The 91% rate of successful directional coronary atherectomy and 98% overall procedural success rate (including subsequent use of conventional angioplasty) reported in our series are consistent with earlier reports (3, 4, (7) (8) (9) (10) 18) . When the procedure was unsuccessful, the most common cause of failure was inability to advance the rigid atherectomy device through a calcified or tortuous vessel segment. The incidence of major complications (emergency coronary artery bypass grafting, Q wave myocardial infarction or death) was low (0.5%), despite the presence of many clinical and angiographic predictors of adverse outcome (lesions that are new, in the left main or right coronary artery, eccentric,;:::10 mm in length, calcified, aorta-ostial, angulated, tortuous or bifurcated, as well as those containing dissections, ulcerations or thrombus) (8-10). Other complication rates including abrupt vessel closure, elevated plasma CK levels and late coronary aneurysm formation were comparable with those seen after conventional angioplasty (15, 21, 22) . Our 7% average residual stenosis after directional coronary atherectomy reflects our philosophy that obtaining low restenosis rates with a new device is predicated on obtaining excellent initial results (12) . In that regard, the 2.25-mm acute gain that we observed with atherectomy was greater than that seen after conventional angioplasty (12, 23, 24) . Popma et al. (10) recently also reported better immediate results with use of larger atherectomy devices, but worse acute results in restenotic lesions, diffuse proximal disease, lesion length ;:::10 mm and calcified lesions.
These excellent acute results were generally obtained without adjunctive conventional angioplasty. Predilation (13% of cases) was reserved for tight new, calcified or aorta-ostial lesions and was not used routinely because of concern that predilation might make subsequent tissue removal more difficult. This result is consistent with the recent observations of the New Approaches for Coronary Intervention Registry (25) . Dilation after successful directional coronary atherectomy (11% of cases) was used only when a significant residual stenosis remained after use of the appropriate size device and higher (40 to 60 psi) balloon inflation pressures, to treat local dissection or to rescue side branches compromised during the procedure. However, the infre-quent use of adjunctive coronary angioplasty does not imply that all improvement in lumen diameter was due to tissue removal: our prior studies (4, 26) showed that up to half of the lumen improvement with directional coronary atherectomy is due to mechanical stretching.
Late Results
Overall results. If defined using a traditional dichotomous definition (~50% diameter stenosis at follow-up angiography), restenosis was observed in 32% of lesions, similar to prior reports (4, (27) (28) (29) (30) (31) (32) . Although the results cannot be directly compared with results of conventional angioplasty because of differences in reference vessel size or lesion location, they may be slightly better than the restenosis rates seen with conventional angioplasty (33) . The Coronary Atherectomy versus Excisional Atherectomy Trial (CAVEAT) is now in progress to assess this possibility in randomized fashion.
Lesion location. There was a trend toward a lower incidence of restenosis for lesions in the right coronary artery, left circumflex coronary artery or saphenous vein graft than for lesions in the left anterior descending artery. To better understand the reasons for these findings, the pathobiology of restenosis may be broken down into the sum of its opposing components: acute gain and late loss (12) . Compared with those in the left anterior descending artery, the improved late results in the right coronary artery and saphenous vein graft appear to be due to either greater acute gain or less late loss. These restenosis data are consistent with those of a recent analysis (34) regarding differences in restenosis after directional coronary atherectomy and stenting. Although the numbers are small, the encouragingly low 28% restenosis rate for saphenous vein graft lesions appears to be lower than that seen after conventional angioplasty (33) . This result may be related in part by the higher proportion of new lesions (77%) and the large size of the vein grafts that we treated, and our observed restenosis rate for saphenous vein graft atherectomy is similar to the 25% restenosis rate obtained with stenting of vein grafts at our institution (19) . As expected, our study shows a trend supporting prior findings of higher restenosis rates for restenotic lesions (27) (28) (29) (30) (31) (32) , corresponding to both less acute gain and greater late loss than that seen in new lesions.
Predictors of restenosis. Prior studies (27) (28) (29) (30) (31) (32) 35) of restenosis rates after directional coronary atherectomy have identified unfavorable late outcomes in lesions that had prior restenosis, ostial or saphenous vein graft location, length ~ 10 mm or percent stenosis < -10% after atherectomy. In our study, however, predictors of unfavorable late results after atherectomy included a smaller «3 mm) postatherectomy lumen diameter, a cholesterol level >200 mg/dl and absence of recent myocardial infarction. The significantly lower restenosis rate when the postatherectomy diameter was >3 mm (Fig. 1) reflects the importance of the acute gain: the larger the postatherectomy diameter, the less likely it is JACC Vol. 20, No. 5 November I, 1992 5 November I, :1101 that subsequent late loss from intimal hyperplasia will compromise the overall result (12) . Although directional coronary atherectomy as such may stimulate more late loss (average I mm) than that seen after conventional balloon angioplasty (average 0.4 mm), the greater acute gain with atherectomy in larger vessels seems to be sufficient to accommodate that increase (12) . Although directional coronary atherectomy can reliably and safely achieve such acute gain, attempts to obtain similar acute gain by conventional angioplasty with oversized balloons unacceptably increases the risk of dissection and abrupt vessel closure (36) . However, this advantage of atherectomy may not carry over to smaller vessels in which small postatherectomy lumen diameters are less able to offset the late loss due to hyperplasia. This hypothesis may explain the higher restenosis rates that we observed in vessels whose postatherectomy lumen diameter was <3 mm.
Cholesterol level obtained at the time of the procedure was also found to be a significant predictor of restenosis, with a restenosis rate of 40% for a serum cholesterol level >200 mg/dl versus 18% for a level :5200 mg/dl (Fig. 2) . Our study shows that this result is not due to a smaller reference vessel or a smaller postatherectomy lumen size in hypercholesterolemic patients. Rather, there appears to be more late loss after directional coronary atherectomy in patients whose cholesterol level is >200 mg/dl at the time of the procedure. Because restenosis after atherectomy is known to be due to intimal hyperplasia rather than to accelerated atherosclerosis (4), the link between a high cholesterol level and greater intimal hyperplasia is unclear. Preliminary studies (37) in humans suggest that lowering cholesterol with lovastatin may reduce the incidence of restenosis, but given the contradictory data (38, 39) relating cholesterol levels to restenosis after conventional angioplasty, a prospective study of the effects of cholesterol on restenosis appears warranted.
The mechanism by which a recent myocardial infarction is associated with a lower rate of restenosis after directional coronary atherectomy is unclear, but there is probably a greater thrombus burden in these lesions. Smaller underlying plaque mass would increase the rate of acute procedural success (9, 40) and possibly allow for a larger postatherectomy lumen diameter, yielding a lower rate of restenosis.
Clinical follow-up. Analysis of our long-term clinical follow-up data shows that the majority. of adverse events occurred within the 1st 6 months after directional coronary atherectomy, and consisted mainly of repeat revascularization procedures (17% of patients underwent coronary angioplasty and 12% underwent coronary artery bypass grafting), including those performed for other than the atherectomytreated lesion. Event-free survival curves then appear to level off between 6 and 12 months with an increase in late deaths (5%lyear) and ongoing repeat events (7%lyear) during the 2nd and 3rd years after the procedure. These late events probably represent the underlying natural history of patients with complex coronary artery disease because late problems with the atherectomy-treated segment remained rare. Although a direct comparison is difficult because of the high (49%) incidence of multivessel disease in our patients who underwent directional coronary atherectomy, the overall survival and event-free survival rates compare favorably with those reported in similar patients after conventional angioplasty (41) .
Histologic findings. Deep wall components (medial adventitia) continue to be retrieved from a significant percent of lesions without either acute clinical sequelae (4, 42, 43) or an increase in the incidence of subsequent restenosis. In fact, we saw a trend toward a lower incidence of restenosis when adventitia was retrieved, suggesting that the beneficial effect of larger posttreatment lumen appears to overshadow any adverse effect that exposure of media and adventitia might provide as a stimulus for greater platelet deposition or aggregation and subsequent smooth muscle cell proliferation. That larger posttreatment lumen diameter is probablY partially due to the weakening of the vessel wall and local expansion (26) . This view is consistent with our prior studies (4, 42) but at variance with one other study (44) . However, recent analysis of a combined patient series from the Beth Israel and Sequoia Hospitals confirm our singlecenter finding that the recovery of deep wall components does not predict subsequent restenosis (45) . Nevertheless, we urge caution in interpretation of these results. Although our data should allay the concern that there is an increased risk of restenosis when media or adventitia is retrieved, we certainly do not recommend that obtaining adventitia should be a goal of the procedure. Rather, one should perform sufficient cuts directed toward the atherosclerotic plaque to obtain optimal angiographic results. Using this approach, we have not seen an increased incidence of acute vessel perforation or late coronary aneurysm formation.
Limitations of the study. There are several important limitations of this study: 1) It is a nonrandomized observational study in patients whose coronary artery anatomy was selected as being suitable for directional coronary atherectomy. Therefore, we cannot make any comparison between our results and those of conventional angioplasty. The CA VEAT randomized trial of directional coronary atherecto my versus conventional balloon angioplasty is currently underway to permit such comparison. 2) Angiographic follow-up was incomplete (77% of patients). Although we cannot accurately predict what the restenosis rate would have been with more complete follow-up, it probably would have been lower because of further dilution of the number of patients with restenosis (who tend to be studied before 6 months because of recurrent symptoms) by additional asymptomatic patients (without restenosis).
3) The cholesterol levels that correlate with increased restenosis were drawn at the time of the procedure, under various medical regimens and clinical conditions, including recent myocardial infarction and unstable angina, that may have altered the absolute cholesterol values. Confirmation of our data with FISHMAN ET AL.
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CORONARY ATHERECTOMY serial cholesterol measurements in a larger series of patients would be appropriate.
Conclusions. Our 3-year experience with directional coronary atherectomy in 225 lesions suggests that the procedure can be performed with excellent success and safety in a group that represents at least 9% of current interventions. We recommend that it be performed so as to achieve the largest possible posttreatment lumen diameter within the constraints of the reference vessel size and avoidance of vessel perforation, but without concern that retrieval of deep wall components (media or adventitia) will increase in the risk of restenosis. Aggressive attempts to lower serum cholesterol levels may also be warranted after the procedure.
